Merycarla Pichardo
Dominican Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Long-Term Outcomes of Recurrent Bulbar Urethral Stricture Treatment With the Optilume Drug-Coated Balloon: Five-Year Results From the ROBUST I Study.
Journal: The Journal of urology
Published: August 30, 2024
Long-term outcomes after treatment with Optilume BPH Four-year results from the EVEREST study.
Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: July 08, 2024
Durable benefit after treatment of obstructive benign prostatic hyperplasia with a novel drug-device combination product: 2-year outcomes from the EVEREST-I study.
Journal: World journal of urology
Published: March 02, 2023
A Drug-Coated Balloon Treatment for Urethral Stricture Disease: Three-Year Results from the ROBUST I Study.
Journal: Research and reports in urology
Published: February 02, 2022
Correction: One-year outcomes after treatment with a drug-coated balloon catheter system for lower urinary tract symptoms related to benign prostatic hyperplasia.
Journal: Prostate cancer and prostatic diseases
Published: July 08, 2021
One-year outcomes after treatment with a drug-coated balloon catheter system for lower urinary tract symptoms related to benign prostatic hyperplasia.
Journal: Prostate cancer and prostatic diseases
Published: December 04, 2020
A drug-coated balloon treatment for urethral stricture disease: Two-year results from the ROBUST I study.
Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: August 04, 2020
A drug-coated balloon treatment for urethral stricture disease: Interim results from the ROBUST I study.
Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: January 25, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026